Llwytho...
Current advances in biomarkers for targeted therapy in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is a complex heterogeneous disease characterized by the absence of three hallmark receptors: human epidermal growth factor receptor 2, estrogen receptor, and progesterone receptor. Compared to other breast cancer subtypes, TNBC is more aggressive, has a higher pr...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Breast Cancer (Dove Med Press) |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Dove Medical Press
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5063595/ https://ncbi.nlm.nih.gov/pubmed/27785100 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S114659 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|